SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-016999
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:18
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 330191
2 ex31-1.htm EX-31.1 6633
3 ex31-2.htm EX-31.2 6660
4 ex32-1.htm EX-32.1 9960
  Complete submission text file 0001493152-24-016999.txt   867628

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ghsi-20231231.xsd EX-101.SCH 26472
6 XBRL DEFINITION FILE ghsi-20231231_def.xml EX-101.DEF 5356
7 XBRL LABEL FILE ghsi-20231231_lab.xml EX-101.LAB 147296
8 XBRL PRESENTATION FILE ghsi-20231231_pre.xml EX-101.PRE 61484
20 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 8326
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

IRS No.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38861 | Film No.: 24891436
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)